Polydatin, a natural polyphenol, protects arterial smooth muscle cells against mitochondrial dysfunction and lysosomal destabilization following hemorrhagic shock

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 7, 2012, Pages

  Wang, Xingmin ^a   Song, Rui ^a   Bian, Hui Ning ^b   Brunk, Ulf T ^c   Zhao, Ming ^a   Zhao, Ke Seng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Hemorrhagic shock; Hypotension; Lysosomes; Polydatin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCEIN; COBALT; CYCLOSPORIN A; HYDROLASE; IRON; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NORADRENALIN; POLYDATIN; POLYPHENOL DERIVATIVE; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME LOCALIZATION; HEMORRHAGIC SHOCK; HYPERPOLARIZATION; LYSOSOME; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CYCLOSPORINE; CYTOPROTECTION; GLUCOSIDES; KATP CHANNELS; LYSOSOMES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL DISEASES; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCYTES, SMOOTH MUSCLE; NOREPINEPHRINE; RATS; SHOCK, HEMORRHAGIC; STILBENES;

EID: 84859559349     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00350.2011     Document Type: Article

References (40)

1. Baines CP. The mitochondrial permeability transition pore and ischemiareperfusion injury. Basic Res Cardiol 104: 181-188, 2009.
2. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 38: 1278-1295, 2005.
3. Chen SJ, Wu CC, Yang SN, Lin CI, Yen MH. Hyperpolarization contributes to vascular hyporeactivity in rats with lipopolysaccharideinduced endotoxic shock. Life Sci 68: 659-68, 2000.
4. Crouser ED, Julian MW, Joshi MS, Bauer JA, Wewers MD, Hart JM, Pfeiffer DR. Cyclosporin A ameliorates mitochondrial ultrastructural injury in the ileum during acute endotoxemia. Crit Care Med 30: 2722-2728, 2002.
5. Curtis K, Grove P. Refractory hypotension in trauma: a case study. Aust Crit Care 13: 52-57, 2000.
6. Dare AJ, Phillips AR, Hickey AJ, Mittal A, Loveday B, Thompson N, Windsor JA. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med 47: 1517-25, 2009.
7. De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn 2nd GW, Kitsis RN, Molkentin JD. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosisindependent model of dilated heart failure. Circ Res 86: 255-263, 2000.
8. Fink MP. Cytopathic hypoxia-mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 17: 219-237, 2001.
9. Gray SD. Rat spinotrapezius muscle preparation for microscopic observation of the terminal vascular bed. Microvasc Res 5: 395-400, 1973.
10. Grimm S, Brdiczka D. The permeability transition pore in cell death. Apoptosis 12: 841-855, 2007.
11. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 61: 372-385, 2004.
12. Hubbard WJ, Bland KI, Chaudry IH. The role of the mitochondrion in trauma and shock. Shock 22: 395-402, 2004.
13. Javadov S, Karmazyn M, Escobales N. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 330: 670-678, 2009.
14. Jin CH, Zhao KS. The effect and mechanism of Polydatin in shock treatment. In: Molecular Mechanism of Severe Shock, edited by Zhao KS and Xu Q. Kerala, India: Research Signpost, p. 191-223, 2009.
15. Jones RA, Smail A, Wilson MR. Detecting mitochondrial permeability transition by confocal imaging of intact cells pinocytically loaded with calcein. Eur J Biochem 269: 3990-3997, 2002.
16. Kakkar R, Ye B, Stoller DA, Smelley M, Shi NQ, Galles K, Hadhazy M, Makielski JC, McNally EM. Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ Res 98: 682-689, 2006.
17. Kerem Z, Bilkis I, Flaishman MA, Sivan L. Antioxidant activity and inhibition of alpha-glucosidase by trans-resveratrol, piceid, and a novel trans-stilbene from the roots of Israeli Rumex bucephalophorus L. J Agric Food Chem 54: 1243-1247, 2006.
18. Kerr PM, Suleiman MS, Halestrap AP. Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am J Physiol Heart Circ Physiol 276: H496-H502, 1999.
19. Kon K, Kim JS, Uchiyama A, Jaeschke H, Lemasters JJ. Lysosomal iron mobilization and induction of the mitochondrial permeability transition in acetaminophen-induced toxicity to mouse hepatocytes. Toxicol Sci 117: 101-108, 2010.
20. Kurz T, Terman A, Gustafsson B, Brunk UT. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol 129: 389-406, 2008.
21. Lange M, Morelli A, Ertmer C, Bröking K, Rehberg S, Van Aken H, Traber DL, Westphal M. Role of adenosine triphosphate-sensitive potassium channel inhibition in shock states: physiology and clinical implications. Shock 28: 394-400, 2007.
22. Liang RN, Mo ZX. Protective effects of polydatin, an active compound from polygonum cuspidatum, on cerebral ischemic damage in rats. Chin Pharmacol Bull 12: 126-129, 1996.
23. Liu J, Zhao KS. The ATP-sensitive K channel and membrane potential in the pathogenesis of vascular hyporeactivity in severe hemorrhagic shock. Chin J Traumatol 15: 39-44, 2003.
24. Merlini L, Angelin A, Tiepolo T, Braghetta P, Sabatelli P, Zamparelli A, Ferlini A, Maraldi NM, Bonaldo P, Bernardi P. Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA 105: 5225-5229, 2008.
25. Petronilli V, Miotto G, Canton M, Colonna R, Bernardi P, and Di Lisa F. Imaging the mitochondrial permeability transition pore in intact cells. Biofactors 8: 263-272, 1998.
26. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411: 77-82, 1997.
27. 2+. Am J Physiol Cell Physiol 299: C506-C515, 2010.
28. Shepherd RK, Checcarelli N, Naini A, De Vivo DC, DiMauro S, Sue CM. Measurement of ATP production in mitochondrial disorders. J Inherit Metab Dis 29: 86-91, 2006.
29. Song R, Bian H, Wang X, Huang X, Zhao KS. Mitochondrial injury underlies hyporeactivity of arterial smooth muscle in severe shock. Am J Hypertens 24: 45-51, 2011.
30. Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev 54: 101-127, 2002.
31. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P, Zhang C, Pacher P, Csiszar A. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 297: H1876-H1881, 2009.
32. Víctor VM, Espulgues JV, Hernández-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets 9: 376-389, 2009.
33. Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Eur J Pharmacol 604: 111-116, 2009.
34. Zhang LP, Yang CY, Wang YP, Cui F, Zhang Y. Protective effect of polydatin against ischemia/reperfusion injury in rat heart. Acta Physiol Sin 60: 161-168, 2008.
35. Zhao KS, Huang XL, Liu J, Huang QB, Jin CH, Jiang Y, Jin JQ, Zhao GL. New approach to treatment of shock-restitution of vasoreactivity. Shock 18: 189-192, 2002.
36. Zhao KS, Junker D, Delano FA, Zweifach BW. Microvascular adjustments during irreversible hemorrhagic shock in rat skeletal muscle. Microvasc Res 30: 143-153, 1985.
37. Zhao KS, Liu J, Jin CH. The role of membrane potential and calcium kinetic changes in the pathogenesis of vascular hyporeactivity during severe shock. Chin Med J 113: 59-64, 2000.
38. Zhao KS. Ion channels and low vasoreactivity in severe shock. In: Molecular Mechanism of Severe Shock, edited by Zhao KS and Xu Q. Kerala, India: Research Signpost, p. 107-129, 2009.
39. Zhao M, Eaton JW, Brunk UT. Protection against oxidant-mediated lysosomal rupture: a new anti-apoptotic activity of Bcl-2? FEBS Lett 485: 104-108, 2000.
40. Zhao Q, Zhao KS. Inhibition of L-type calcium channels in arteriolar smooth muscle cells is involved in the pathogenesis of vascular hyporeactivity in severe shock. Shock 28: 717-721, 2007.